Trisalus Life Sciences (TLSI) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on May 14, 2026, with stockholders able to vote and ask questions online.

• Four main proposals are up for vote: election of two directors, ratification of the independent auditor, advisory vote on executive compensation frequency, and advisory vote on executive compensation.

• Proxy materials are distributed electronically to reduce costs and environmental impact, with options for printed copies upon request.

Voting matters and shareholder proposals

• Stockholders will vote to elect two directors (Mary Szela and Gary Gordon) for three-year terms expiring at the 2029 Annual Meeting.

• Ratification of Grant Thornton LLP as independent auditor for fiscal year 2026 is proposed.

• Advisory votes include the frequency of say-on-pay (Board recommends every three years) and approval of named executive officer compensation.

• Board recommends voting for all proposals as presented.

Board of directors and corporate governance

• The Board is divided into three classes with staggered three-year terms; currently seven members, majority independent.

• Board committees include Audit, Compensation, Nominating and Corporate Governance, and Science and Technology, each with defined responsibilities and independent membership.

• Board leadership is separated, with an independent Chair (Mats Wahlström) and CEO roles.

• Director nominations can be made by stockholders following specific procedures.

• Board diversity is considered, though no formal policy exists.